Refractory chronic cough (RCC), defined as a persistent cough for more than 8 weeks despite adequate treatment of underlying comorbidities, is increasingly acknowledged as a standalone clinical ...

GSK PLC closed 2.64% short of its 52-week high of £16.85, which the company reached on October 2nd.

--GSK has lately posted lower vaccine sales in China and the U.S., and faces pressure to show that its pipeline includes new blockbuster drugs to counter concerns about that slowdown, AJ Bell ...

GSK plc ( NYSE: GSK) and Syndivia on Monday announced an agreement granting GSK exclusive worldwide rights to develop and ...

Deutsche Bank Research raises London Stock Exchange price target to 11,900 (11,500) pence - 'buy' Deutsche Bank Research raises Reckitt Benckiser price target to 5,700 (5,600) pence - 'hold' Comments ...

(Alliance News) - GSK PLC on Monday announced an agreement with Syndivia that grants GSK exclusive worldwide rights to develop and commercialise a preclinical antibody-drug conjugate for metastatic ...

Fresh from a European cancer conference that was all about antibody-drug conjugates (ADCs), GSK has turned to French biotech ...

GSK said it acquired exclusive worldwide rights for a drug candidate targeting prostate cancer from France's Syndivia for up to 268 million pounds ($356.8 million).

With a name derived from the Latin word for “to help,” adjuvants are pharmaceutical substances that increase the intensity of immune response when administered with a vaccine or other medication. They ...

The China National Medical Products Administration (NMPA) has approved Shingrix (GSK's Recombinant Zoster Vaccine or RZV) for ...

Indonesia relocates residents due to Caesium-137 contamination; New York and California support Planned Parenthood against federal funding cuts; English doctors strike for job security and pay; US ...

The FDA has approved belantamabmafodotin (Blenrep) in combination with bortezomib (Velcade) and dexamethasone (BVd)for the ...